Hemant Surgical Industries Limited (BOM:543916)
India · Delayed Price · Currency is INR 285.00
-8.50 (-2.90%)
At close: Feb 13, 2026
BOM:543916 Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 |
Operating Revenue | 1,224 | 1,066 | 1,056 | 1,091 | 1,036 | 597.65 |
Other Revenue | - | 0 | - | - | - | - |
| 1,224 | 1,066 | 1,056 | 1,091 | 1,036 | 597.65 | |
Revenue Growth (YoY) | 15.15% | 0.97% | -3.24% | 5.39% | 73.30% | 6.28% |
Cost of Revenue | 885.98 | 765.6 | 782.48 | 815.55 | 824.29 | 478.69 |
Gross Profit | 337.89 | 300.77 | 273.6 | 275.93 | 211.41 | 118.96 |
Selling, General & Admin | 118.82 | 111.71 | 120.64 | 111.15 | 79.68 | 57.18 |
Other Operating Expenses | 75.14 | 86.42 | 48.25 | 59.08 | 68.74 | 26.51 |
Operating Expenses | 208.75 | 212.38 | 179.15 | 178.73 | 155.91 | 90.03 |
Operating Income | 129.14 | 88.39 | 94.45 | 97.2 | 55.51 | 28.93 |
Interest Expense | -34.56 | -22.73 | -9.45 | -16.87 | -16.08 | -18.01 |
Interest & Investment Income | 5.92 | 5.92 | 11.21 | 5.24 | 1.24 | 1.58 |
Currency Exchange Gain (Loss) | 1.4 | 1.4 | 13.56 | 14.74 | 4.91 | -4.53 |
Other Non Operating Income (Expenses) | 16.15 | 13.51 | 8.69 | 0.49 | 2.91 | 2.7 |
EBT Excluding Unusual Items | 118.04 | 86.49 | 118.46 | 100.8 | 48.48 | 10.67 |
Gain (Loss) on Sale of Assets | 1.78 | 1.78 | - | -0.23 | - | - |
Other Unusual Items | -11.65 | -11.65 | - | - | - | - |
Pretax Income | 136.21 | 104.66 | 127.81 | 100.57 | 61.12 | 15.2 |
Income Tax Expense | 33.03 | 24.25 | 29.81 | 24.2 | 14.98 | 3.75 |
Net Income | 103.19 | 80.41 | 98 | 76.37 | 46.14 | 11.45 |
Net Income to Common | 103.19 | 80.41 | 98 | 76.37 | 46.14 | 11.45 |
Net Income Growth | 9.43% | -17.95% | 28.32% | 65.52% | 302.86% | 128.42% |
Shares Outstanding (Basic) | 13 | 10 | 10 | 7 | 5 | 5 |
Shares Outstanding (Diluted) | 13 | 10 | 10 | 7 | 5 | 5 |
Shares Change (YoY) | 44.07% | 4.93% | 33.66% | 44.60% | - | - |
EPS (Basic) | 7.99 | 7.70 | 9.85 | 10.26 | 8.96 | 2.22 |
EPS (Diluted) | 7.96 | 7.70 | 9.85 | 10.26 | 8.96 | 2.22 |
EPS Growth | -24.07% | -21.82% | -4.00% | 14.50% | 303.60% | 128.87% |
Free Cash Flow | -287.13 | -287.33 | -130.8 | 23.69 | 116.41 | -26.59 |
Free Cash Flow Per Share | -22.14 | -27.52 | -13.15 | 3.18 | 22.61 | -5.17 |
Gross Margin | 27.61% | 28.21% | 25.91% | 25.28% | 20.41% | 19.90% |
Operating Margin | 10.55% | 8.29% | 8.94% | 8.91% | 5.36% | 4.84% |
Profit Margin | 8.43% | 7.54% | 9.28% | 7.00% | 4.46% | 1.92% |
Free Cash Flow Margin | -23.46% | -26.95% | -12.38% | 2.17% | 11.24% | -4.45% |
EBITDA | 143.93 | 102.64 | 104.71 | 105.7 | 62.99 | 35.28 |
EBITDA Margin | 11.76% | 9.63% | 9.92% | 9.68% | 6.08% | 5.90% |
D&A For EBITDA | 14.79 | 14.26 | 10.26 | 8.5 | 7.49 | 6.34 |
EBIT | 129.14 | 88.39 | 94.45 | 97.2 | 55.51 | 28.93 |
EBIT Margin | 10.55% | 8.29% | 8.94% | 8.91% | 5.36% | 4.84% |
Effective Tax Rate | 24.25% | 23.17% | 23.33% | 24.06% | 24.51% | 24.67% |
Revenue as Reported | 1,274 | 1,118 | 1,099 | 1,115 | 1,058 | 606.52 |
Advertising Expenses | - | 4.72 | 5.75 | 9.89 | 2.01 | 1.88 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.